Mauricette Michallet Selected Research

inolimomab

1/2017	A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD.
1/2007	Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease.
9/2005	Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other interleukin-2 receptor antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mauricette Michallet Research Topics

Disease

48	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 01/2002
31	Leukemia 01/2023 - 12/2002
20	Neoplasms (Cancer) 04/2024 - 08/2003
20	Multiple Myeloma 06/2019 - 02/2002
19	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 07/2002
19	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 07/2002
16	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 12/2006
13	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 01/2004
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 12/2012
9	Infections 01/2019 - 03/2005
7	Lymphoma (Lymphomas) 01/2019 - 05/2008
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 11/2011
6	Pathologic Complete Response 11/2019 - 06/2006
5	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2014
5	Hematologic Diseases (Blood Diseases) 01/2019 - 02/2012
4	Bronchiolitis Obliterans Syndrome 01/2018 - 11/2002
4	Neutropenia 04/2016 - 06/2010
4	Anemia 01/2016 - 03/2005
4	Chromosome Aberrations (Chromosome Abnormalities) 08/2015 - 07/2008
3	Disease Progression 01/2020 - 02/2009
3	Aspergillosis 06/2015 - 10/2011
3	Primary Myelofibrosis (Myelosclerosis) 11/2014 - 02/2011
3	Blast Crisis (Blast Phase) 11/2011 - 01/2011
2	Residual Neoplasm 01/2023 - 04/2017
2	Mycoses (Diseases, Fungus) 04/2022 - 11/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2019 - 05/2007
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 12/2017
2	Candidemia 01/2018 - 01/2013
2	Candidiasis (Moniliasis) 01/2018 - 11/2012
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2017 - 01/2010
2	Hodgkin Disease (Hodgkin's Disease) 12/2017 - 02/2009
2	Hemorrhagic Cystitis 04/2016 - 07/2009
2	Thrombocytopenia (Thrombopenia) 09/2012 - 02/2011
2	Invasive Fungal Infections 10/2011 - 07/2009
1	Persistent Infection 04/2021
1	Dysbiosis 01/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020
1	Monosomy 01/2020
1	Agammaglobulinemia (Hypogammaglobulinemia) 06/2019
1	Sudden Infant Death (SID) 06/2019
1	Inflammation (Inflammations) 02/2019

Drug/Important Bio-Agent (IBA)

11	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 01/2002
10	Tyrosine Kinase InhibitorsIBA 01/2021 - 10/2010
9	Imatinib Mesylate (Gleevec)FDA Link 10/2013 - 04/2003
6	fludarabineIBA 01/2023 - 01/2004
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 01/2004
5	Bortezomib (Velcade)FDA Link 12/2017 - 03/2008
4	Busulfan (Busulfex)FDA Link 01/2023 - 02/2013
3	Immunoglobulins (Immunoglobulin)IBA 04/2021 - 01/2016
3	inolimomabIBA 01/2017 - 09/2005
3	AntigensIBA 08/2015 - 02/2011
3	HLA Antigens (Human Leukocyte Antigens)IBA 04/2015 - 12/2006
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014 - 01/2007
3	Lenalidomide (CC 5013)FDA Link 05/2013 - 05/2012
3	Dexamethasone (Maxidex)FDA LinkGeneric 03/2013 - 10/2010
2	venetoclaxIBA 11/2023 - 01/2023
2	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 12/2012
2	Antifungal AgentsIBA 01/2021 - 10/2011
2	treosulfanIBA 01/2020 - 08/2012
2	ibrutinibIBA 01/2020 - 01/2019
2	purineIBA 11/2019 - 12/2014
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2018 - 05/2014
2	SteroidsIBA 01/2017 - 09/2005
2	Cidofovir (Vistide)FDA Link 04/2016 - 07/2009
2	HematinicsIBA 01/2016 - 01/2013
2	Biosimilar PharmaceuticalsIBA 01/2016 - 07/2014
2	HomoharringtonineIBA 05/2015 - 10/2010
2	Immunomodulating AgentsIBA 12/2013 - 10/2013
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2013 - 01/2010
2	AntibodiesIBA 10/2012 - 09/2005
2	AnthracyclinesIBA 08/2011 - 02/2010
2	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2011 - 02/2010
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 02/2010 - 01/2002
2	Monoclonal AntibodiesIBA 01/2007 - 09/2005
2	bcr-abl Fusion ProteinsIBA 12/2003 - 04/2003
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2003 - 04/2003
1	CarbonIBA 04/2024
1	Amsacrine (AMSA)IBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022
1	olaparibIBA 12/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Amino Acids FDA Link 01/2020
1	Ferritins (Ferritin)IBA 02/2019

Therapy/Procedure

51	Transplantation 01/2023 - 11/2002
44	Stem Cell Transplantation 01/2021 - 02/2002
42	Hematopoietic Stem Cell Transplantation 01/2023 - 12/2002
33	Therapeutics 01/2023 - 01/2004
26	Drug Therapy (Chemotherapy) 01/2023 - 03/2005
17	Cell Transplantation 02/2024 - 10/2008
15	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2022 - 08/2003
6	Induction Chemotherapy 01/2021 - 06/2007
6	Homologous Transplantation 01/2019 - 04/2012
5	Autologous Transplantation 01/2023 - 07/2008
5	Salvage Therapy 01/2020 - 03/2008
4	Photopheresis 02/2024 - 10/2008
2	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2022 - 12/2006
2	Artificial Respiration (Mechanical Ventilation) 04/2016 - 11/2012
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 06/2015 - 02/2002
1	Tertiary Prevention 04/2024
1	Fecal Microbiota Transplantation 01/2021